Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.

Enlivex Therapeutics Ltd.

We’ve identified three of the best cheap stocks to buy today. Price is important to us all, especially during tough economic times. That is true in...

3 Best Cheap Stocks to Buy Now: 04/29/26

Enlivex ( ($ENLV) ) has issued an update. On April 8, 2026, Enlivex announced that Ondo Finance has launched ENLVon, a tokenized representation of ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ENLV	$0.82	-0.46%	283.21K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ENLV	$0.82	-0.5%	283.21K
3
4
5
6

ENLV

ENLV

Latest News for ENLV

Get Enlivex Therapeutics Ltd. Data in Excel

Get Enlivex Therapeutics Ltd. Data in Excel